BioSpace News Archive

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that it has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb. JTX-8064 is a highly-selective, potential first-in-class antibody that targets the Leukocyte Immunoglobulin Like Receptor B2 (LILRB2) on macrophages, and was licensed to Celgene in J

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the company will participate in the BIO International Convention, which will be held in a new, virtual event format for 2020, known as BIO Digital, from June 8-12, 2020. Sabrina Martucci Johnson, President and CEO of Daré Bioscience, will participate in a panel discussion titled Redefining BioPharma in a Female-Forward World and will separately provid

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 41 st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020 at 3:00 p.m. Eastern Time. A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com . A replay of the webcast will be available on Kiniksa’s website for 14 days following the

Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview at two upcoming investor conferences in June. Goldman Sachs 41 st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 2:10 p.m.

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced the appointment of Gianluca Pirozzi, M.D., Ph.D. and Edward J. Sitar t

Reflect Scientific, Inc. (Symbol:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced a record first quarter in sales. In 2019 new market opportunities were sought in the biopharmaceutical and natural products extraction markets. The result was an improved blast freezer design with first in class specifications for the biopharmaceutical market and a solvent chiller for na

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Lota S. Zoth, CPA to its Board of Directors and as Chair of the Audit Committee. A veteran of the biopharmaceutical industry, Ms. Zoth brings more than 35 years of financial and strategic experience to her role.

Company to host first webinar on Wednesday, June 17, to review OV935 (soticlestat) development program for rare developmental and epileptic encephalopathies (DEE)

Ebb Therapeutics ™ (Ebb) has announced that world-renowned sleep expert Dr. Michael Breus will serve as a Sleep Advisor to the brand. In this role, Dr. Breus - whose expertise in

IQ4I Research & Consultancy published a new report on “Cancer Diagnostics Global Market – Forecast To 2026".